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(article begins on next page) 
To the editor, 
 
Congratulations to Suzie Ferrie and co-investigators for evaluating the protein dose 
recommendations in a randomized pragmatic study.1 The studies’ treatment allocation and 
blinding were conducted in a state-of-the-art design and multiple patient centered outcome 
variables were evaluated at fixed time points independent of ICU discharge status.  
Higher amino acid intake -even though it didn’t affect the primary outcome- apparently 
attenuated muscle wasting and weakness. This finding is in contrast with other recent RCT’s, 
where even larger doses of intravenous amino acids did not improve functional outcome.2 As 
the authors speculate, the moderate disease severity may explain attenuated anabolic 
resistance in their  patients.1 In both RCT’s,1, 2 the important mortality benefit with increased 
amino acid intake, predicted by several large observational prospective studies, was not 
confirmed.3, 4 This is consistent with the general finding that results from non-randomized 
studies are  less likely to be replicated in RCTs.5  
 
Actually the number of patients who died in ICU was slightly higher in the high amino acid 
group 8 (14%) as compared to 6 (10%) in the lower amino-acid group, a difference reaching 
10% at 6 months landmark mortality evaluation.1 Could the authors clarify how non-surviving 
patients were dealt with in the evaluation of the primary and secondary functional outcome 
analyses?  These mortality differences are not statistically significant and may well be 
independent of the high amino acid therapy, yet they may have affected functional outcomes 
as competing events.6 As stated in the methods section “missing values for the primary 
outcome were assumed to be missing at random”. In ICU however it is difficult to accept that 
patients who died would have been –if they survived- as strong as other patients, precluding 
the assumption of being “missed at random”. The few additional deaths in the high amino 
acid arm may paradoxically have improved the results for the primary outcome, by 
eliminating two very low hand grip strength values in this group. Could the authors conduct a 
sensitivity analysis attributing the lowest hand grips strength values to patients who were dead 
at ICU discharge and likewise for patients dead at last hand grip assessment (day 7)? Could 
the authors also report the results for the secondary analyses after imputation of missing 
values, as these have been conducted but are actually not shown in the manuscript? 
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